Matthew H Harms, MD in Lawrence, KS - Medicare Hospitalist

Matthew H Harms, MD is a medicare enrolled "Internal Medicine" physician in Lawrence, Kansas. He went to University Of Kansas School Of Med (kc/wich/sal) and graduated in 1996 and has 28 years of diverse experience with area of expertise as Hospitalist. He is a member of the group practice Lawrence Physicians Llc and his current practice location is 325 Maine St, Lawrence, Kansas. You can reach out to his office (for appointments etc.) via phone at (785) 505-6100.

Matthew H Harms is licensed to practice in Kansas (license number 0427446) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1063421931.

Contact Information

	Matthew H Harms, MD
	325 Maine St, Lawrence, KS 66044-1360
	(785) 505-6100
	(785) 505-2874

Physician's Profile

Full Name	Matthew H Harms
Gender	Male
Speciality	Hospitalist
Experience	28 Years
Location	325 Maine St, Lawrence, Kansas
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Matthew H Harms attended and graduated from University Of Kansas School Of Med (kc/wich/sal) in 1996

NPI Data:

NPI Number: 1063421931
Provider Enumeration Date: 08/07/2006
Last Update Date: 03/01/2022

Medicare PECOS Information:

PECOS PAC ID: 2567477839
Enrollment ID: I20060208000628

Medical Identifiers

Medical identifiers for Matthew H Harms such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1063421931	NPI	-	NPPES
200389980A	Medicaid	KS

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207R00000X	Internal Medicine	0427446 (Kansas)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Lawrence Memorial Hospital	Lawrence, KS	Hospital
Lawrence Memorial Hospital Snf	Lawrence, KS	Nursing home

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Lawrence Physicians Llc	1951623834	179

News Archive

Immunological differences in Moderna and Pfizer-BioNTech vaccine-induced Fc-functional profiles

A new study analyzed the post-boost binding and functional capacity of the humoral response induced by the Pfizer-BioNTech and Moderna vaccines.

U.N., U.S. Peace Corps sign agreement to work together to tackle food insecurity in 76 countries

"The United Nations and the United States Peace Corps signed an agreement [Thursday] to cooperate in combating worldwide hunger by increasing food security in the 76 countries where the more than 8,600 U.S. volunteers currently work," the U.N. News Centre reports.

Aerpio Therapeutics doses first patient in AKB-9778 Phase 2 trial for diabetic macular edema treatment

Aerpio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases, today announced that it has dosed the first patient in a Phase 2 trial evaluating AKB-9778, a Tie2 activator, alone and in combination with ranibizumab (Lucentis) for the treatment of diabetic macular edema (DME). AKB-9778 is a first-in-class inhibitor of human protein tyrosine phosphatase beta (HPTPβ) that activates the Tie2 pathway to promote vascular stability, preventing abnormal blood vessel growth and vascular leak.

Alimta receives positive endorsement for lung cancer approval from FDA Advisory Committee

Eli Lilly and Company have announced that the Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration positively endorsed Alimta® (pemetrexed), an antifolate, for accelerated approval in the second-line treatment of non-small cell lung cancer.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Matthew H Harms allows following entities to bill medicare on his behalf.

Entity Name	Lawrence Physicians Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1346657590 PECOS PAC ID: 1951623834 Enrollment ID: O20141203002058

News Archive

Immunological differences in Moderna and Pfizer-BioNTech vaccine-induced Fc-functional profiles

A new study analyzed the post-boost binding and functional capacity of the humoral response induced by the Pfizer-BioNTech and Moderna vaccines.

U.N., U.S. Peace Corps sign agreement to work together to tackle food insecurity in 76 countries

Aerpio Therapeutics doses first patient in AKB-9778 Phase 2 trial for diabetic macular edema treatment

Alimta receives positive endorsement for lung cancer approval from FDA Advisory Committee

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Matthew H Harms is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Matthew H Harms, MD 325 Maine St, Lawrence, KS 66044-1360 Ph: (785) 505-6100	Matthew H Harms, MD 325 Maine St, Lawrence, KS 66044-1360 Ph: (785) 505-6100

News Archive

Immunological differences in Moderna and Pfizer-BioNTech vaccine-induced Fc-functional profiles

A new study analyzed the post-boost binding and functional capacity of the humoral response induced by the Pfizer-BioNTech and Moderna vaccines.

U.N., U.S. Peace Corps sign agreement to work together to tackle food insecurity in 76 countries

Aerpio Therapeutics doses first patient in AKB-9778 Phase 2 trial for diabetic macular edema treatment

Alimta receives positive endorsement for lung cancer approval from FDA Advisory Committee

Internal Medicine Doctors in Lawrence, KS

Steve Richard Krebs, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 325 Maine St, Lawrence, KS 66044 Phone: 785-505-6100 Fax: 785-505-6149
Dr. Sharon E. Soule, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 330 Arkansas St, Suite 105, Lawrence, KS 66044 Phone: 785-840-2800 Fax: 785-840-2813
Donald W Hatton, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 404 Maine St, Lawrence, KS 66044 Phone: 785-842-3635 Fax: 785-842-8645
Krishna Rangarajan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1130 W 4th St, Suite 2001, Lawrence, KS 66044 Phone: 785-505-3205 Fax: 785-505-5261
Joy-ann Tabanor-gayle, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4525 W 6th St Ste 100, Lawrence, KS 66049 Phone: 785-505-5160 Fax: 785-505-5282
Jennifer Rosenblatt, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2415 Massachusetts St, Lawrence, KS 66046 Phone: 785-843-3750

Matthew H Harms, MD - Medicare Hospitalist in Lawrence, KS

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Immunological differences in Moderna and Pfizer-BioNTech vaccine-induced Fc-functional profiles

U.N., U.S. Peace Corps sign agreement to work together to tackle food insecurity in 76 countries

Aerpio Therapeutics doses first patient in AKB-9778 Phase 2 trial for diabetic macular edema treatment

Alimta receives positive endorsement for lung cancer approval from FDA Advisory Committee

Medicare Reassignments

Immunological differences in Moderna and Pfizer-BioNTech vaccine-induced Fc-functional profiles

U.N., U.S. Peace Corps sign agreement to work together to tackle food insecurity in 76 countries

Aerpio Therapeutics doses first patient in AKB-9778 Phase 2 trial for diabetic macular edema treatment

Alimta receives positive endorsement for lung cancer approval from FDA Advisory Committee

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Immunological differences in Moderna and Pfizer-BioNTech vaccine-induced Fc-functional profiles

U.N., U.S. Peace Corps sign agreement to work together to tackle food insecurity in 76 countries

Aerpio Therapeutics doses first patient in AKB-9778 Phase 2 trial for diabetic macular edema treatment

Alimta receives positive endorsement for lung cancer approval from FDA Advisory Committee

Internal Medicine Doctors in Lawrence, KS